Boewer C, Nawka S, Fleck H, Uibel M, Immer U, Schmidt H E, Herzmann H, Pilgrim G, Ziegenbein R
Z Urol Nephrol. 1985 Feb;78(2):77-86.
In 28 patients with non-seminomatous testicle tumour the tumour markers human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) were determined radioimmunologically and enzymeimmunologically, respectively. While tumours with chorionic carcinoma (n = 8) always were marker-positive, in the embryonic carcinoma in 2 out of 10 cases falsely negative findings appeared. On 5 patients the biochemical monitoring of the course of the testicle tumour disease is demonstrated in detail by means of HCG and AFP and estimated as very helpful method. Advantages and problems of the marker diagnostics are shown and discussed. The positive marker findings were absolutely evident for a metastasation. On the other hand, marker negativation was not always to be equated with absence of a tumour and demanded a further control of the patient by means of all other available methods of diagnostics up to the second-look-operation.
对28例非精原细胞瘤性睾丸肿瘤患者,分别采用放射免疫法和酶免疫法测定肿瘤标志物人绒毛膜促性腺激素(HCG)和甲胎蛋白(AFP)。绒毛膜癌肿瘤(n = 8)总是标志物阳性,而胚胎癌中有2/10的病例出现假阴性结果。通过HCG和AFP对5例患者睾丸肿瘤疾病的病程进行了详细的生化监测,并被评估为非常有用的方法。展示并讨论了标志物诊断的优点和问题。标志物阳性结果对于转移是绝对明显的。另一方面,标志物阴性并不总是等同于无肿瘤,需要通过所有其他可用的诊断方法对患者进行进一步检查,直至二次探查手术。